Hot Alert: Capricor Therapeutics, Inc. (NASDAQ:CAPR), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Nationstar Mortgage Holdings Inc. (NYSE:NSM), Atmos Energy Corporation (NYSE:ATO), aTyr Pharma (NASDAQ:LIFE)

Capricor Therapeutics, Inc. (NASDAQ:CAPR) belongs to Healthcare sector. Its weekly performance is 2.23%. On last trading day company shares ended up $5.00. Capricor Therapeutics, Inc. (NASDAQ:CAPR) distance from 50-day simple moving average (SMA50) is -10.98%. Capricor Therapeutics, Inc. (NASDAQ:CAPR) accepted the resignation of Andrew Hamer, M.D., Vice President of Medical Affairs. Dr. Hamer’s resignation will be effective on or about July 30, 2015.

KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) shares moved down -15.20% in last trading session and ended the day at $0.39. KBIO return on assets is -79.40%. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) quarterly performance is -40.89%. KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO), announced that it will effect a reverse stock split at a ratio of one share of newly issued common stock for each eight shares of issued and outstanding common stock. KaloBios anticipates that the reverse stock split will be effective at 5:00 p.m. Eastern Daylight Time on July 13, 2015, and that its common stock will commence trading on a split-adjusted basis as of the opening of trading on July 14, 2015.

On 13 July, Nationstar Mortgage Holdings Inc. (NYSE:NSM) shares moved down -0.18% and was closed at $16.91. NSM EPS growth in last 5 year was 35.90%. Nationstar Mortgage Holdings Inc. (NYSE:NSM) year to date (YTD) performance is -40.01%. Nationstar Mortgage Holdings Inc. (NYSE:NSM) announced the hiring of Steve Covington as Chief Compliance Officer and Tony Ebers as Executive Vice President of Originations.

Atmos Energy Corporation (NYSE:ATO) ended the last trading day at $53.53. Company weekly volatility is calculated as 1.85% and price to cash ratio as 56.62. Atmos Energy Corporation (NYSE:ATO) showed a weekly performance of 2.10%. Zacks upgraded shares of Atmos Energy (NYSE:ATO) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. The firm currently has $58.00 price target on the stock.

aTyr Pharma Inc. (NASDAQ:LIFE) shares moved up 5.94% in last trading session and ended the day at $19.45. LIFE return on assets is -149.10%. aTyr Pharma, Inc. (NASDAQ: LIFE), announced the resignation of President and Chief Operating Officer Frederic Chereau to pursue other opportunities, effective immediately.

Leave a Reply

Your email address will not be published. Required fields are marked *